George Dranitsaris is an oncology research pharmacist with graduate training in pharmacoeconomics, biostatistics, decision analysis and clinical epidemiology. His areas of interest include the measurement of cost effective drug use in the oncology setting, cancer supportive care research, value based drug pricing, and the application of statistical modeling techniques to evaluate drug performance outside of the trial setting. He has over 100 publications in the national and international literature, is past president of the Canadian Association of Pharmacy in Oncology, a statistical reviewer for the Journal of Clinical Oncology and a member of the editorial board of the Journal of Oncology Pharmacy Practice and the European Journal of Hospital Pharmacy Science.